BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 10914721)

  • 1. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.
    Biegel JA; Fogelgren B; Zhou JY; James CD; Janss AJ; Allen JC; Zagzag D; Raffel C; Rorke LB
    Clin Cancer Res; 2000 Jul; 6(7):2759-63. PubMed ID: 10914721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.
    Judkins AR; Mauger J; Ht A; Rorke LB; Biegel JA
    Am J Surg Pathol; 2004 May; 28(5):644-50. PubMed ID: 15105654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene.
    Kraus JA; Oster C; Sörensen N; Berthold F; Schlegel U; Tonn JC; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 2002 Apr; 28(2):136-41. PubMed ID: 11972800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
    J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
    Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
    Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
    Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
    BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
    Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
    Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
    Tsai CY; Wong TT; Lee YH; Chao ME; Lin SC; Liu DJ; Liang ML; Wang HW; Ho DM
    Am J Surg Pathol; 2012 Jan; 36(1):128-33. PubMed ID: 22020042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
    Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
    Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
    Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
    Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of INI1 in sporadic human brain tumors.
    Weber M; Stockhammer F; Schmitz U; von Deimling A
    Acta Neuropathol; 2001 May; 101(5):479-82. PubMed ID: 11484819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
    Packer RJ; Biegel JA; Blaney S; Finlay J; Geyer JR; Heideman R; Hilden J; Janss AJ; Kun L; Vezina G; Rorke LB; Smith M
    J Pediatr Hematol Oncol; 2002; 24(5):337-42. PubMed ID: 12142780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the rhabdoid predisposition syndrome in a child: a novel germline hSNF5/INI1 mutation and absence of c-myc amplification.
    Fujisawa H; Takabatake Y; Fukusato T; Tachibana O; Tsuchiya Y; Yamashita J
    J Neurooncol; 2003 Jul; 63(3):257-62. PubMed ID: 12892231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.
    Versteege I; Sévenet N; Lange J; Rousseau-Merck MF; Ambros P; Handgretinger R; Aurias A; Delattre O
    Nature; 1998 Jul; 394(6689):203-6. PubMed ID: 9671307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors.
    Miller S; Ward JH; Rogers HA; Lowe J; Grundy RG
    Brain Pathol; 2013 Jan; 23(1):19-27. PubMed ID: 22672440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.